Borreliacidal OspC Antibody Response of Canines with Lyme Disease Differs Significantly from That of Humans with Lyme Disease

Documenti analoghi

• Bacterin That Induces Anti-OspA and Anti-OspC Borreliacidal Antibodies Provides a High Level of Protection against Canine Lyme Disease
  di: LaFleur, Rhonda L., et al.
  Pubblicazione: (2009)
• Significantly Improved Accuracy of Diagnosis of Early Lyme Disease by Peptide Enzyme-Linked Immunosorbent Assay Based on the Borreliacidal Antibody Epitope of Borrelia burgdorferi OspC
  di: Jobe, Dean A., et al.
  Pubblicazione: (2008)
• Rapid Decline of OspC Borreliacidal Antibodies following Treatment of Patients with Early Lyme Disease
  di: Jobe, Dean A., et al.
  Pubblicazione: (2011)
• Borreliacidal OspC Antibodies Specific for a Highly Conserved Epitope Are Immunodominant in Human Lyme Disease and Do Not Occur in Mice or Hamsters
  di: Lovrich, Steven D., et al.
  Pubblicazione: (2005)
• Borreliacidal OspC Antibodies Specific for a Highly Conserved Epitope Are Immunodominant in Human Lyme Disease and Do Not Occur in Mice or Hamsters
  di: Lovrich, Steven D., et al.
  Pubblicazione: (2005)